OrganiGram Holdings Net Worth
OrganiGram Holdings Net Worth Breakdown | OGI |
OrganiGram Holdings Net Worth Analysis
OrganiGram Holdings' net worth analysis, or its valuation, is the process of determining the total value of the company. This involves assessing a range of factors, including OrganiGram Holdings' financial performance, assets, liabilities, and potential for growth. The ultimate goal is to provide a clear understanding of OrganiGram Holdings' overall worth, which can help investors make informed investment decisions. There are several methods that can be used to perform OrganiGram Holdings' net worth analysis. One common approach is to calculate OrganiGram Holdings' market capitalization.Another approach is to use the price-to-earnings ratio (P/E ratio), which compares OrganiGram Holdings' stock price to its earnings per share (EPS). Discounted cash flow (DCF) analysis is another popular method for assessing OrganiGram Holdings' net worth. This approach calculates the present value of OrganiGram Holdings' future cash flows, taking into account factors such as growth rate, profitability, and risk. By comparing the present value of OrganiGram Holdings' cash flows to its current stock price, investors can gain a better understanding of the company's overall value. Finally, investors may use comparable company analysis to evaluate OrganiGram Holdings' net worth. This involves comparing OrganiGram Holdings' financial metrics to similar companies in the same industry. By identifying companies with similar financial characteristics, investors can gain insight into OrganiGram Holdings' net worth relative to its peers.
Enterprise Value |
|
To determine if OrganiGram Holdings is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding OrganiGram Holdings' net worth research are outlined below:
| OrganiGram Holdings generated a negative expected return over the last 90 days | |
| OrganiGram Holdings may become a speculative penny stock | |
| The company reported the last year's revenue of 149.21 M. Reported Net Loss for the year was (229.48 M) with profit before taxes, overhead, and interest of 35.07 M. | |
| OrganiGram Holdings has about 127.36 M in cash with (35.8 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.41. | |
| OrganiGram Holdings has a frail financial position based on the latest SEC disclosures | |
| Roughly 31.0% of the company outstanding shares are owned by corporate insiders |
OrganiGram Holdings uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in OrganiGram Holdings. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to OrganiGram Holdings' previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 1st of February 2024 Upcoming Quarterly Report | View | |
| 9th of April 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 17th of December 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 30th of September 2023 Last Financial Announcement | View |
Know OrganiGram Holdings' Top Institutional Investors
Have you ever been surprised when a price of an equity instrument such as OrganiGram Holdings is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading OrganiGram Holdings backward and forwards among themselves. OrganiGram Holdings' institutional investor refers to the entity that pools money to purchase OrganiGram Holdings' securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Two Sigma Advisers, Llc | 2024-06-30 | 101.2 K | Morgan Stanley - Brokerage Accounts | 2024-06-30 | 49.3 K | Jane Street Group Llc | 2024-06-30 | 48.5 K | Graham Capital Management | 2024-09-30 | 45.4 K | Vontobel Holding Ltd. | 2024-06-30 | 40.6 K | Clear Harbor Asset Management, Llc | 2024-09-30 | 32.8 K | State Of Wyoming | 2024-06-30 | 28.9 K | Hightower Advisors, Llc | 2024-06-30 | 23 K | Pfs Partners, Llc | 2024-09-30 | 19 K | Tidal Investments Llc. | 2024-09-30 | 1.9 M | Renaissance Technologies Corp | 2024-09-30 | 893.4 K |
Follow OrganiGram Holdings' market capitalization trends
The company currently falls under 'Small-Cap' category with a total capitalization of 166.96 M.Market Cap |
|
Project OrganiGram Holdings' profitablity
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.03) | (0.03) | |
| Return On Capital Employed | (0.07) | (0.08) | |
| Return On Assets | (0.02) | (0.03) | |
| Return On Equity | (0.03) | (0.03) |
When accessing OrganiGram Holdings' net worth, it's important to look at multiple sources and consider different scenarios. For example, gross profit margin measures OrganiGram Holdings' profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of OrganiGram Holdings' profitability and make more informed investment decisions.
Evaluate OrganiGram Holdings' management efficiency
OrganiGram Holdings has Return on Asset of (0.0556) % which means that on every $100 spent on assets, it lost $0.0556. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of (0.5453) %, meaning that it generated no profit with money invested by stockholders. OrganiGram Holdings' management efficiency ratios could be used to measure how well OrganiGram Holdings manages its routine affairs as well as how well it operates its assets and liabilities. The current Return On Tangible Assets is estimated to decrease to -0.03. The current Return On Capital Employed is estimated to decrease to -0.08. As of now, OrganiGram Holdings' Intangible Assets are increasing as compared to previous years. The OrganiGram Holdings' current Intangibles To Total Assets is estimated to increase to 0.10, while Total Assets are projected to decrease to under 251.2 M.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 6.58 | 6.91 | |
| Tangible Book Value Per Share | 5.85 | 3.06 | |
| Enterprise Value Over EBITDA | 30.29 | 31.81 | |
| Price Book Value Ratio | 0.86 | 0.82 | |
| Enterprise Value Multiple | 30.29 | 31.81 | |
| Price Fair Value | 0.86 | 0.82 | |
| Enterprise Value | 336.2 M | 278.7 M |
At OrganiGram Holdings, effective management practices are pivotal to sustaining long-term profitability. We delve into financial metrics and market conditions to provide a comprehensive analysis of the stock's prospects.
Enterprise Value Revenue 0.9494 | Revenue 149.2 M | Quarterly Revenue Growth (0.14) | Revenue Per Share 1.835 | Return On Equity (0.55) |
OrganiGram Holdings Earnings per Share Projection vs Actual
OrganiGram Holdings Corporate Management
| CPA CPA | Chief Officer | Profile | |
| Beena Goldenberg | CEO Director | Profile | |
| Helen Martin | Chief Secretary | Profile | |
| Katrina McFadden | Chief Officer | Profile | |
| Megan McCrae | Senior Communications | Profile | |
| Amy Schwalm | VP Relations | Profile | |
| CFA CA | Chief Officer | Profile |
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in OrganiGram Holdings. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. For more detail on how to invest in OrganiGram Stock please use our How to Invest in OrganiGram Holdings guide.You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of OrganiGram Holdings. If investors know OrganiGram will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about OrganiGram Holdings listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.80) | Revenue Per Share 1.835 | Quarterly Revenue Growth (0.14) | Return On Assets (0.06) | Return On Equity (0.55) |
The market value of OrganiGram Holdings is measured differently than its book value, which is the value of OrganiGram that is recorded on the company's balance sheet. Investors also form their own opinion of OrganiGram Holdings' value that differs from its market value or its book value, called intrinsic value, which is OrganiGram Holdings' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because OrganiGram Holdings' market value can be influenced by many factors that don't directly affect OrganiGram Holdings' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between OrganiGram Holdings' value and its price as these two are different measures arrived at by different means. Investors typically determine if OrganiGram Holdings is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, OrganiGram Holdings' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.